Focal neuroinflammation is considered one of the hypotheses for the cause of temporal lobe epilepsy (TLE) with amygdala enlargement (AE). Here, we report a case involving an adult female patient with TLE-AE characterized by late-onset seizures and cognitive impairment. Anti--methyl-d-aspartate receptor (NMDAR) antibodies were detected in her cerebrospinal fluid. However, administration of appropriate anti-seizure drugs (ASD), without immunotherapy, improved TLE-AE associated with NMDAR antibodies. In the present case, two clinically significant observations were made: 1) anti-NMDAR antibody-mediated autoimmune processes may be associated with TLE-AE, and 2) appropriate administration of ASD alone can improve clinical symptoms in mild cases of autoimmune epilepsy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120426PMC
http://dx.doi.org/10.1016/j.ebcr.2018.07.005DOI Listing

Publication Analysis

Top Keywords

anti--methyl-d-aspartate receptor
8
temporal lobe
8
lobe epilepsy
8
amygdala enlargement
8
nmdar antibodies
8
improvement anti--methyl-d-aspartate
4
receptor antibody-mediated
4
antibody-mediated temporal
4
epilepsy amygdala
4
enlargement immunotherapy
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!